Pharmacovigilance practice among pediatric neurologists from Poland and Germany.

Autor: Kopciuch D; Department of Pharmacoeconomics and Social Pharmacy, Poznan University of Medical Sciences, Rokietnicka 7 St, 60-806, Poznań, Poland. dkoligat@ump.edu.pl., Kus K; Department of Pharmacoeconomics and Social Pharmacy, Poznan University of Medical Sciences, Rokietnicka 7 St, 60-806, Poznań, Poland., Niśkiewicz I; Department of Neurology, Martin-Luther-University Hospital Halle- Wittenberg, Halle, Germany., Fliciński J; Department of Developmental Neurology, Poznan University of Medical Sciences, Poznan, Poland., Zaprutko T; Department of Pharmacoeconomics and Social Pharmacy, Poznan University of Medical Sciences, Rokietnicka 7 St, 60-806, Poznań, Poland., Ratajczak P; Department of Pharmacoeconomics and Social Pharmacy, Poznan University of Medical Sciences, Rokietnicka 7 St, 60-806, Poznań, Poland., Nowakowska E; Department of Pharmacology and Toxicology Institute of Health Sciences, Collegium Medicum, University of Zielona Gora, Góra, Poland., Hoffmann K; Department of Internal Diseases, Metabolic Disorders and Arterial Hypertension, Poznan University of Medical Sciences, Poznan, Poland., Koligat-Seitz A; Department of Otolaryngology, Greater Poland Pediatric Center, Poznan, Poland., Bryl W; Department of Internal Diseases, Metabolic Disorders and Arterial Hypertension, Poznan University of Medical Sciences, Poznan, Poland., Paczkowska A; Department of Pharmacoeconomics and Social Pharmacy, Poznan University of Medical Sciences, Rokietnicka 7 St, 60-806, Poznań, Poland.
Jazyk: angličtina
Zdroj: BMC medical education [BMC Med Educ] 2023 Aug 01; Vol. 23 (1), pp. 547. Date of Electronic Publication: 2023 Aug 01.
DOI: 10.1186/s12909-023-04542-4
Abstrakt: Objectives: To compare the pediatric neurologists' knowledge, practice, and barriers to the pharmacovigilance (PV) process in Poland and Germany.
Methods: The research tool was an online anonymous questionnaire on Google Forms e-mailed to pediatric neurologists from Poland and Germany.
Results: The questionnaires were handed out to 830 pediatric neurologists and 371 expressed their consent to participate in the study. Most of the neurologists were familiar with the definition of PV and adverse drug reactions (ADRs). Only 34.10% of pediatric neurologists from Poland, and 38.88% from Germany believe that many ADRs are preventable and almost most of them believe it is necessary to report ADRs from children with epilepsy. Unfortunately, in opposite to this knowledge, only 37.79% of respondents from Poland and 40.32% from Germany felt co-responsible for reporting ADRs. The main reason for the neurologists not to report ADRs was a conviction that reporting ADRs would be an additional burden generating extra work.
Conclusion: There is no big difference between the practice of PV by pediatric neurologists in Poland and Germany. System-regulated PV stabilization in the country translates into the practice of maintaining PV. Monitoring the safety of pharmacotherapy and knowledge of risks associated with ADRs should be included in the curricula of academic neurologics courses.
(© 2023. The Author(s).)
Databáze: MEDLINE
Externí odkaz: